Literature DB >> 4538535

Poliomyelitis in the Netherlands 1958-69: the influence of a vaccination programme with inactivated poliovaccine.

B Hofman.   

Abstract

The Netherlands is one of the few countries where poliomyelitis vaccination is practised with inactivated vaccine. Vaccinations started in 1957 and since 1962 have been carried out with a diphtheria-tetanus-pertussis-poliomyelitis vaccine according to a fixed schedule. The overall acceptance rate has been over 90%.Since 1957 the poliomyelitis morbidity has decreased by more than 99% in fully vaccinated persons and by 60-80% among nonvaccinated persons. The latter reduction probably resulted from a decrease in the amount of virus circulating after the vaccination campaign had started. The rather unequal distribution of acceptance rates allowed for a more detailed examination, which showed a relation between acceptance rates and morbidity figures. The morbidity pattern is now characterized by a few local outbreaks among nonvaccinated subjects in areas with low vaccination rates, and by the virtual disappearance of the disease in the rest of the country.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4538535      PMCID: PMC2480877     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.

Authors:  F T PERKINS; R YETTS; W GAISFORD
Journal:  Br Med J       Date:  1959-03-14

2.  Serological response of infants to poliomyelitis vaccine.

Authors:  F T PERKINS; R YETTS; W GAISFORD
Journal:  Br Med J       Date:  1958-07-12

3.  Poliomyelitis surveillance in England and Wales, 1965-8.

Authors:  D L Miller; D Reid; J R Diamond
Journal:  Public Health       Date:  1970-09       Impact factor: 2.427

4.  Neurovirulence of polioviruses isolated form sewage and stool of healthy children. II. Neurovirulence of strains and types 1 and 3.

Authors:  J D Verlinde; J B Wilterdink
Journal:  Arch Gesamte Virusforsch       Date:  1970

5.  A longitudinal study on the significance of examination of sewage for the presence of poliovirus in the population.

Authors:  J B Wilterdink; H T Weiland; J D Verlinde
Journal:  Arch Gesamte Virusforsch       Date:  1970

6.  Neurovirulence of polioviruses isolated from sewage and stool of healthy children. I. Studies on neurovirulence, antigenic marker and RCT-40 mrker of type 2 strains.

Authors:  J B Wilterdink; G L Smit; J D Verlinde
Journal:  Arch Gesamte Virusforsch       Date:  1969

7.  [Poliomyelitis epidemic in Staphorst].

Authors:  H Bijkerk; F J Draaisma; T Landheer; M van Os
Journal:  Ned Tijdschr Geneeskd       Date:  1972-04-01

8.  Poliomyelitis in the Netherlands before and after vaccination with inactivated poliovaccine.

Authors:  B Hofman
Journal:  J Hyg (Lond)       Date:  1967-12

9.  A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.

Authors:  J L Henry; E S Jaikaran; J R Davies; A J Tomlinson; P J Mason; J M Barnes; A J Beale
Journal:  J Hyg (Lond)       Date:  1966-03

10.  [Poliomyelitis antibody determination 10 years after vaccination with inactivated Salk virus vaccine].

Authors:  B Hofman
Journal:  Ned Tijdschr Geneeskd       Date:  1971-07-03
  10 in total
  3 in total

1.  Pertussis in a rural area of Kenya: epidemiology and a preliminary report on a vaccine trial.

Authors:  J M Mahieu; A S Muller; A M Voorhoeve; H Dikken
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

2.  Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes.

Authors:  B Cvjetanović; B Grab; H Dixon
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 3.  Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992.

Authors:  H C Rümke; P M Oostvogel; G Van Steenis; A M Van Loon
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.